2014 Genetics and mental health Pharmaceuticals 
Mad in America
NOVEMBER 13, 2023
Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 695 This is sickening.
Mad in America
SEPTEMBER 20, 2024
I didn’t know Wallace was a poster boy for antidepressant withdrawal because I didn’t know that antidepressant withdrawal was common, or that I would be experiencing it myself and understanding firsthand the hellish bodily and mental feelings that make one long for death, for everything to stop. There are no studies, not yet.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
MARCH 20, 2024
Mad in America has previously examined the problems with conflicts of interest in research but this time we extend that to look at the potential effect of COIs on diagnostic tools such as the Diagnostic and Statistical Manual of Mental Disorders (DSM). He wanted his friends to use this drug, he wanted his family members to use this drug.
Mad in America
AUGUST 5, 2024
Within this, some parts of the neurodiversity movement take an uncritical or neutral perspective on the validity of psychiatric diagnoses such as—but not limited to—ASD and ADHD, backed up by unsubstantiated claims about biological and genetic causal factors. This heterogeneity makes it difficult to generalise.
Mad in America
OCTOBER 21, 2023
Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five decades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mental health is getting worse by multiple metrics. As of late 2022, just 31% of U.S.
Expert insights. Personalized for you.
142 
Let's personalize your content